Literature DB >> 3393195

Reticuloendothelial clearance in cystic fibrosis and other inflammatory lung diseases.

E C Mantzouranis1, F S Rosen, H R Colten.   

Abstract

To examine the possible pathophysiologic role of circulating immune complexes in patients with cystic fibrosis and other inflammatory lung diseases, we studied the reticuloendothelial clearance of IgG-sensitized autologous erythrocytes in 15 patients with cystic fibrosis, 6 with chronic obstructive lung disease not related to cystic fibrosis, 7 with immunodeficiencies, 5 with systemic lupus erythematosus, 4 who had previously undergone a splenectomy, and 10 normal subjects. Patients with chronic inflammation and recurrent infections (i.e., those with cystic fibrosis, chronic obstructive lung disease, and immunodeficiencies) had significantly faster clearance rates (P less than 0.05, less than 0.01, and less than 0.005, respectively) than normal subjects. In contrast, patients with systemic lupus erythematosus (a classic immune complex-mediated disease) and those who had undergone a splenectomy had delayed clearance. The accelerated reticuloendothelial clearance in patients with chronic inflammatory pulmonary disease associated with cystic fibrosis was similar to that observed in stimulated laboratory animals. The rapid clearance rate may account for the rareness of septicemia in such patients despite chronic, persistent local bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3393195     DOI: 10.1056/NEJM198808113190604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  5 in total

Review 1.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.

Authors:  Alix Ashare; Clark Stanford; Patricia Hancock; Donna Stark; Kathleen Lilli; Emily Birrer; Amanda Nymon; Kevin C Doerschug; Gary W Hunninghake
Journal:  Clin Transl Sci       Date:  2009-06       Impact factor: 4.689

3.  Intact splenic function in cystic fibrosis.

Authors:  N J Barrios; M Kiernan; R Beckerman; S Davis
Journal:  J Natl Med Assoc       Date:  1994-04       Impact factor: 1.798

4.  Pseudomonas aeruginosa bacteremia and prostatitis in a patient with cystic fibrosis.

Authors:  Anju Anand; Elizabeth Tullis; Anne Stephenson; J Curtis Nickel; Michael J Leveridge
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

5.  Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.

Authors:  Fumihiro Sanada; Yoshiaki Taniyama; Junya Azuma; Ikeda-Iwabe Yuka; Yasuhiro Kanbara; Masaaki Iwabayashi; Hiromi Rakugi; Ryuichi Morishita
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2014-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.